category guide

How to choose orthopedic capital equipment

April 30, 2026· 10 min read· AI-generated

How to choose orthopedic capital equipment

A procurement guide for hospital VACs, ASC administrators, and biomed engineers navigating powered tools, imaging, tables, and implant systems.

What this is and who buys it

Orthopedic capital equipment is a deliberately broad category — it encompasses powered surgical instruments (drills, saws, reamers, oscillators), intraoperative imaging systems (full-size and mini C-arms), specialty procedure tables (fracture/traction, radiolucent OR tables), and the implant and instrumentation systems used in trauma, joint reconstruction, spine, and sports medicine. No single purchase defines an orthopedic program; most facilities are managing a portfolio of interdependent equipment that needs to work together in the same sterile field, often simultaneously.

Buyers range from hospital value analysis committees (VACs) overseeing multi-OR trauma programs to ASC administrators standing up an outpatient total joint line, and from orthopedic group practices bringing fluoroscopy in-house to critical-access hospitals replacing an aging C-arm fleet. The procurement trigger matters: a new anterior hip program has different imaging and table requirements than a trauma call expansion, and a first-time ASC buildout has different risk tolerance than a fleet refresh at a high-volume academic center.

The market is also moving fast. Outpatient total joints, robotics-assisted arthroplasty, and flat-panel fluoroscopy have all shifted what "baseline" looks like in the last five years. A fleet purchased in 2016 may be technically functional but clinically obsolete relative to current surgeon expectations and documentation standards.

Key decision factors

Procedure mix should drive the specification, not the other way around. Before opening a single RFP, audit your top 10–15 CPT codes by volume and project the next three years realistically. A pure sports medicine and extremity practice has almost no use case for a full-size C-arm; mini C-arms are now the standard of care for in-room fluoroscopy in those settings. Conversely, a trauma program handling acetabular fractures and intramedullary nailing needs a full-size system with a working envelope large enough to cover the pelvis and femur without repositioning.

Imaging performance — dose, field of view, and detector technology — is the spec that most buyers underweight. Flat-panel detectors offer meaningfully higher soft-tissue resolution and reduced patient dose compared with older image-intensifier tubes, and their larger active detector area eliminates the geometric distortion common in legacy systems [S12]. When evaluating any C-arm, request the entrance dose rate in pulsed fluoroscopy mode (not continuous mode), confirm last-image-hold and live zoom without additional dose, and verify that ALARA-compliant dose-tracking is built in — not an add-on subscription.

Table radiolucency and imaging window dimensions deserve the same rigor as the C-arm specification. For anterior approach hip arthroplasty, trauma reduction, and spine, the unobstructed imaging window needs to accommodate both your patient population's weight range and your existing C-arm's base footprint. Premium fracture table platforms achieve weight capacities around 507 lbs (230 kg) with 360-degree radiolucent surfaces [S11]; verify these numbers against your C-arm's source-to-image distance before purchase, not after delivery.

The power tool ecosystem — battery chemistry, sterilization compatibility, and attachment interoperability — is often the most underdiscussed factor at the VAC table. Lithium-ion batteries now dominate modern orthopedic power platforms because of their low memory effect, consistent power-delivery curve throughout discharge, and better energy density relative to earlier NiCd or NiMH chemistries [S7]. That said, "lithium-ion" is not a single standard: confirm the battery cycle count rating, the autoclave cycle tolerance per handpiece, and whether your SPD's sterile-transfer workflow (sterile vs. aseptic transfer) matches the vendor's validated process.

Implant and instrumentation standardization is a supply-chain and patient-safety argument, not just a cost argument. Every additional implant vendor adds tray count, sterile processing time, and surgeon-credentialing overhead. A reasonable consolidation target for a mid-size orthopedic program is one to two primary vendors per service line — trauma, arthroplasty, spine — with documented escape clauses if surgeon panel changes occur.

Total cost of ownership, modeled over seven years, routinely diverges from sticker price by 8–12% in hidden costs — installation, staff training, facility modifications, and service contracts [S13]. That gap is wider for imaging systems than for power tools, and wider still for navigation and robotics. Build a 7-year TCO model before the capital committee meets, not as an afterthought.

What it costs

Orthopedic capital equipment spans nearly three orders of magnitude in price, which makes category-level budgeting almost meaningless without procedure-specific scoping. The ranges below reflect current market data; OEM list prices are rarely publicly published, so treat these as planning inputs rather than contract targets.

Entry: $15,000–$75,000. Refurbished mini C-arms in this range ($15K–$65K depending on detector type, image quality, and remaining tube life) [S8], basic battery-powered drill systems, and used general OR tables. Appropriate for low-volume ASCs, office-based practices, and mission settings.
Mid: $75,000–$300,000. New mini C-arms from established manufacturers (new units from prominent brands frequently exceed $70,000) [S8], refurbished full-size flat-panel C-arms, premium power tool consoles with multiple handpiece configurations, and dedicated fracture tables. This is the most active segment for ASCs and community hospital ORs.
Premium: $300,000+. New full-size flat-panel C-arms, premium orthopedic/fracture table platforms with full accessory sets, navigation systems, and robotics-assisted joint platforms — which can reach $1M or more per system before per-case disposable costs are factored in. These investments require a formal volume-and-reimbursement business case, not just surgeon enthusiasm.

Common use cases

The right equipment configuration looks quite different depending on the setting and case mix.

Hospital orthopedic ORs running trauma call: Full-size C-arm with flat-panel detector, modular fracture/traction table, and a multi-handpiece powered tool console fleet — with a loaner-coverage agreement for any single point of failure.
Ambulatory surgery centers doing outpatient total joints and arthroscopy: Mini C-arm or compact mobile C-arm, lightweight radiolucent tables, and either a compact battery tool kit or single-use power tools for high-efficiency turnover.
Office-based orthopedic and podiatry practices: In-office fluoroscopy for fracture reduction and injection guidance — a mini C-arm in this setting can generate $40,000–$80,000 or more in additional annual revenue at 8–12 procedures per week by eliminating hospital-based imaging referrals [S10].
Critical-access and rural hospitals: Refurbished imaging systems with verified parts availability and remote diagnostics capability, paired with multi-specialty tables that can serve both orthopedic and general surgery needs.

Regulatory and compliance

Orthopedic devices in the U.S. are governed primarily under 21 CFR Part 888 (Orthopedic Devices), administered by FDA's Center for Devices and Radiological Health. The classification tier determines the regulatory pathway: Class I instruments — general manual surgical instruments, drill guides, non-powered goniometers — are typically exempt from 510(k) premarket notification. Class II devices, which cover most powered tools, C-arms, many implants, and surgical planning instruments (e.g., product code PBF under 21 CFR 888.3030), require 510(k) clearance before marketing [S1]. Recent FDA orders have codified Class II with special controls for orthopedic manual instrumentation used with total disc replacement devices (21 CFR 888.4515) and non-fusion spinous process spacer devices (21 CFR 888.4520) [S3, S4]. High-risk spinal implants and some total disc replacements may require a full PMA (Class III). For every line item on a vendor quote, verify the 510(k) number in FDA's public database before executing a contract.

Standards compliance runs across multiple bodies. Electrical safety for any powered device or imaging system should conform to IEC 60601-1 (general medical electrical safety) and, for C-arms specifically, IEC 60601-2-43 (interventional X-ray systems). Manufacturer quality management systems should be certified to ISO 13485. Implant metallurgy should meet ASTM F138/F136 (surgical-grade stainless and titanium alloys) and/or the ISO 5832 series. Sterilization validation — your SPD's responsibility, not the vendor's — should follow AAMI ST79 for steam sterilization. Importantly, state radiation control programs independently license fluoroscopy operators and set PM frequency requirements for fluoroscopy machines; confirm your state's specific requirements before installation [S9]. Any imaging system integrated with a PACS or EHR triggers HIPAA obligations for data security and audit logging.

Service, training, and total cost of ownership

For powered surgical tools, plan on a 7–10 year service life with annual preventive maintenance, battery replacement every two to three years, and handpiece refurbishment as needed. The economics here are relatively predictable. C-arms are a different story: PM visits from OEM or third-party ISOs run $850–$2,000 per visit [S9], and most new or refurbished systems carry only a one-year warranty before you're buying a service contract — typically $8,000–$15,000 per year for a full-size system [S9]. Third-party ISO contracts are generally 30–40% less expensive than OEM, with parts savings that can reach 50%, but the tradeoff is potential exclusion from OEM software updates and, in some cases, voided manufacturer warranties [S9]. For fracture and specialty OR tables, expect a 12–15 year service life with annual electrical and mechanical PM.

Installation is not plug-and-play. Any C-arm requires EMC verification and radiation safety sign-off; navigation and robotic systems may require room shielding modifications. Budget two to five days for applications training on imaging systems and one to three days for power tool platforms — and insist that this training be included in the contract, not sold separately. Before signing, demand a written parts-availability commitment of at least seven years post-purchase; ECRI Institute has documented cases where parts for discontinued imaging platforms become unavailable within four years of the last sale.

Red flags to watch for

A quote that excludes installation, freight, in-service training, and first-year PM is structurally misleading — these costs can add 8–12% to the capital line and will surface eventually [S13]. Walk away from any vendor who cannot produce a 510(k) number or FDA registration for every SKU on the quote; this is not an administrative formality, it is a safety and liability issue verifiable in minutes at the FDA's public 510(k) database [S5]. Be cautious of service contracts marketed as "lifetime" or "comprehensive" that bury exclusions for X-ray tubes, flat-panel detectors, and batteries — the three components most likely to fail in an imaging system. On the implant side, sole-source consigned tray agreements without explicit escape clauses create serious stranded-inventory risk when a surgeon changes practice affiliation, a more common scenario than most VACs plan for.

Questions to ask vendors

Provide the FDA 510(k) number, product code, and 21 CFR classification regulation for every line item on this quote, along with the IEC 60601 edition the device is tested against.
What is the fully loaded 7-year cost of ownership — itemizing PMs, battery replacements, tube/detector replacement, consumables, and software subscriptions — and what is explicitly excluded?
What is your guaranteed parts-availability window post-purchase, and what are your contractual mean-time-to-repair and on-site response SLAs?
For C-arms: what are the entrance dose rates in pulsed fluoroscopy mode, and does DICOM/PACS integration require third-party middleware or additional licensing fees?
For power tools: what is the validated autoclave cycle count per handpiece, the battery cycle life, and the current replacement cost for a battery and motor assembly?
What loaner or backup equipment is provided during unplanned downtime, and is that coverage written into the service contract or discretionary?

Alternatives

The new-versus-refurbished question in orthopedic imaging is genuinely nuanced. A refurbished full-size or mini C-arm can deliver 40–60% capital savings versus new, which for a low-to-moderate-volume facility may represent the difference between affording the program or not [S8]. The real tradeoffs are remaining tube and detector life, limited access to current OEM software versions, and shorter warranty periods. Refurbished equipment is a rational choice when it comes with a documented refurbishment checklist, tube-hour count, detector calibration certificate, and a credible ISO service agreement.

On financing, operating leases preserve capital and bundle service but typically cost more over a 5–7 year horizon than purchase plus a service contract — often 15–25% more on a cumulative basis. Capital leases and Section 179 expensing (the 2026 deduction limit is $2,560,000 with 100% bonus depreciation) frequently produce better TCO outcomes for facilities with steady, predictable utilization. Independent practices and smaller hospitals that haven't already done so should route orthopedic equipment purchasing through a GPO or MSO; documented savings in orthopedic categories run 10–30% off list [S14], and MSOs also vet supplier quality and negotiate service terms that most individual practices lack the leverage to secure on their own. Finally, single-use power tools — now widely available for trauma and arthroscopy — eliminate sterilization overhead and PM complexity entirely; they make economic sense in ASC settings where case volume per system is below roughly 8–15 per month.

Sources

Browse vendors in

Orthopedics

MedSource publishes neutral guidance. We do not accept payment from vendors to influence the content of articles. AI-generated articles are reviewed for factual accuracy but cited sources should be the primary reference for procurement decisions.